Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Allergan Loses Another Battle, But War To Block Restasis Generics Continues

Jan 19 2018

• By Brenda Sandburg

Eye

Related Content

Mohawk Tribe Questions Patent Board's Impartiality In Restasis Case

Jan 05 2018

Allergan May Rue Mohawk Tribe Deal As Court Invalidates Restasis Patents

Oct 17 2017

Biosimilar Litigation: Genentech Avastin Suit Tossed; Janssen Remicade Case Uncertain

Mar 03 2017

FTC’s ‘Awesome’ Suit Against Shire Targets Citizen Petitions

Feb 09 2017

Related Companies

Allergan plc

Viatris Inc.

AbbVie Inc.

Takeda Pharmaceutical Co. Ltd.

Teva Pharmaceutical Industries Ltd.

Akorn, Inc.

Additional Topics

United States Generic Drugs Intellectual Property Legal Issues FDA Regulation Ophthalmic BioPharmaceutical

More from Generics

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.